Expression of 5-LOX in ovarian cancer under hypoxia and its clinical significance

liu hui,zheng guixi,zou mingjin,du lutao,zhang xin,yang yongmei,zhang yi,wang chuanxin

DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2017.10.036

2017-01-01

Abstract:Objective: To detect the expression level of 5-LOX in ovarian cancer,explore the correlations between 5-LOX expression and clinicopathological features,and investigate its effect on the development and treatment of ovarian cancer.Methods: The expressions of 5-LOX and HIF-1α in 56 ovarian cancer specimens was examined by immunohistochemistry,and the correlations between 5-LOX expression and clinicopathological features were further analyzed.The human ovarian cancer SKOV3 cells were cultivated 0 h,12 h,24 h,48 h respectively under hypoxia environment,and then RNA and protein were extracted. Quantitative real-time PCR(qRT-PCR) was used to measure the mRNA expression level of 5-LOX.Western blot was used to measure the protein expression level of 5-LOX. ELISA was used to measure the change of 5-HETE.Result: Immunohistochemistry results showed that 5-LOX level was correlated with HIF-1α level,and its level was significantly correlated with lymph nodes metastasis,distant metastasis and clinical stage.5-LOX was up regulation both in transcription and protein levels in ovarian cancer SKOV3 cells under hypoxia.The 5-HETE level was also increased under hypoxia.Conclusions: Hypoxia can promote the expression of 5-LOX and increase its metabolites 5-HETE in ovarian cancer,suggesting 5-LOX can be a potential target for the treatment of ovarian cancer,which provides a new thought and method in the pathogenesis and treatment for ovarian cancer.